| Identification | Back Directory | [Name]
Aurora Kinase Inhibitor II | [CAS]
331770-21-9 | [Synonyms]
IUN-70219
Aurora kinase inhibitor-2
N-(4-((6,7-Dimethoxyquinazolin-4-yl)amino)phenyl)benzamide
inhibit,Aurora-A,Aurora kinase inhibitor2,Aurora Kinase,ATP-competitive,Aurora kinase inhibitor 2,Aurora kinase inhibitor-2,Aurora-B,Inhibitor | [Molecular Formula]
C23H20N4O3 | [MDL Number]
MFCD13191283 | [MOL File]
331770-21-9.mol | [Molecular Weight]
400.43 |
| Chemical Properties | Back Directory | [Boiling point ]
518.6±50.0 °C(Predicted) | [density ]
1.321±0.06 g/cm3(Predicted) | [storage temp. ]
4°C, protect from light | [solubility ]
DMF:0.25(Max Conc. mg/mL);0.62(Max Conc. mM)
DMF:PBS(pH7.2) (1:2):0.33(Max Conc. mg/mL);0.82(Max Conc. mM)
DMSO:2.5(Max Conc. mg/mL);6.2(Max Conc. mM) | [form ]
A crystalline solid | [pka]
13.01±0.70(Predicted) | [color ]
White to yellow |
| Hazard Information | Back Directory | [Description]
The Aurora kinases are a family of serine/threonine kinases that are key regulators of mitosis and cytokinesis. Aurora kinase inhibitor II is a cell-permeable anilinoquinazoline that blocks the activity of Aurora A (IC50 = 0.39 μM). In MCF-7 cells, it blocks proliferation with an IC50 value of 1.25 μM. | [Uses]
Aurora kinase inhibitor-2 is a selective and ATP-competitive Aurora kinase inhibitor with IC50s of 310 nM and 240 nM for Aurora A and Aurora B, respectively[1]. | [IC 50]
Aurora A: 310 nM (IC50); Aurora B: 240 nM (IC50) | [References]
[1] Andrew A Mortlock, et al. Progress in the development of selective inhibitors of aurora kinases. Curr Top Med Chem. 2005;5(8):807-21. DOI:10.2174/1568026054637719
[2] Nicola M Heron, et al. SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1320-3. DOI:10.1016/j.bmcl.2005.11.053 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
|